Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer

Standard

Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer. / Ambrosini, Francesca; Falkenbach, Fabian; Budaeus, Lars; Graefen, Markus; Koehler, Daniel; Lischewski, Flemming; Gschwend, Juergen E; Heck, Matthias; Eiber, Matthias; Knipper, Sophie; Maurer, Tobias.

In: MINERVA UROL NEPHROL, Vol. 75, No. 6, 12.2023, p. 734-742.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Ambrosini, F, Falkenbach, F, Budaeus, L, Graefen, M, Koehler, D, Lischewski, F, Gschwend, JE, Heck, M, Eiber, M, Knipper, S & Maurer, T 2023, 'Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer', MINERVA UROL NEPHROL, vol. 75, no. 6, pp. 734-742. https://doi.org/10.23736/S2724-6051.23.05445-9

APA

Ambrosini, F., Falkenbach, F., Budaeus, L., Graefen, M., Koehler, D., Lischewski, F., Gschwend, J. E., Heck, M., Eiber, M., Knipper, S., & Maurer, T. (2023). Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer. MINERVA UROL NEPHROL, 75(6), 734-742. https://doi.org/10.23736/S2724-6051.23.05445-9

Vancouver

Bibtex

@article{84082aa4c3bd4eeeb4626d74bf1c41d9,
title = "Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer",
abstract = "BACKGROUND: Defining the best surgical template for salvage lymph node dissection (SLND) in patients exhibiting unilateral prostate cancer (PCa) recurrence in pelvic lymph nodes (LNs) is an unmet need. We assessed the risk of missing contralateral nodal recurrence in patients with unilateral positive PSMA-PET who were treated with bilateral PSMA-radioguided (RGS) SLND.METHODS: Patients who consecutively underwent bilateral PSMA-radioguided SLND for PCa recurrence between April 2014 and January 2023 were identified. We compared PSMA PET findings with the number and the location of PCa LN metastases of the final pathological report. Univariable logistic regression models to try to predict contralateral missed disease were performed.RESULTS: Sixty patients were identified. At PSMA-RGS, the median PSA level was 0.71 ng/mL (IQR: 0.38-2.28). At PSMA-PET pre-SLND, 49 (82%) patients had unilateral exclusively pelvic lesions, 2 (3%) had unilateral positive nodes at the level of the common iliac arteries, and 9 (15%) had unilateral positive nodes in both levels. Final pathology revealed unilateral LN involvement in 43 (72%), a negative report in 3 (5%), and bilateral positive lesions in 14 (23%) patients. In the univariable logistic regression models, none of the tested factors showed influence on missing contralateral lesions. Four patients out of 35 (11%) with one positive LN at PSMA-PET had bilateral PCa recurrence.CONCLUSIONS: Patients with one-sided positive LNs on PSMA PET can be considered for a unilateral PSMA-radioguided SLND template with the caveat that about a quarter of patients ultimately have bilateral positive LNs. Larger prospective randomized trials are needed to confirm our findings.",
keywords = "Male, Humans, Prevalence, Prospective Studies, Neoplasm Recurrence, Local/diagnostic imaging, Prostatic Neoplasms/diagnostic imaging, Positron-Emission Tomography",
author = "Francesca Ambrosini and Fabian Falkenbach and Lars Budaeus and Markus Graefen and Daniel Koehler and Flemming Lischewski and Gschwend, {Juergen E} and Matthias Heck and Matthias Eiber and Sophie Knipper and Tobias Maurer",
year = "2023",
month = dec,
doi = "10.23736/S2724-6051.23.05445-9",
language = "English",
volume = "75",
pages = "734--742",
journal = "MINERVA UROL NEPHROL",
issn = "2724-6051",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

RIS

TY - JOUR

T1 - Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer

AU - Ambrosini, Francesca

AU - Falkenbach, Fabian

AU - Budaeus, Lars

AU - Graefen, Markus

AU - Koehler, Daniel

AU - Lischewski, Flemming

AU - Gschwend, Juergen E

AU - Heck, Matthias

AU - Eiber, Matthias

AU - Knipper, Sophie

AU - Maurer, Tobias

PY - 2023/12

Y1 - 2023/12

N2 - BACKGROUND: Defining the best surgical template for salvage lymph node dissection (SLND) in patients exhibiting unilateral prostate cancer (PCa) recurrence in pelvic lymph nodes (LNs) is an unmet need. We assessed the risk of missing contralateral nodal recurrence in patients with unilateral positive PSMA-PET who were treated with bilateral PSMA-radioguided (RGS) SLND.METHODS: Patients who consecutively underwent bilateral PSMA-radioguided SLND for PCa recurrence between April 2014 and January 2023 were identified. We compared PSMA PET findings with the number and the location of PCa LN metastases of the final pathological report. Univariable logistic regression models to try to predict contralateral missed disease were performed.RESULTS: Sixty patients were identified. At PSMA-RGS, the median PSA level was 0.71 ng/mL (IQR: 0.38-2.28). At PSMA-PET pre-SLND, 49 (82%) patients had unilateral exclusively pelvic lesions, 2 (3%) had unilateral positive nodes at the level of the common iliac arteries, and 9 (15%) had unilateral positive nodes in both levels. Final pathology revealed unilateral LN involvement in 43 (72%), a negative report in 3 (5%), and bilateral positive lesions in 14 (23%) patients. In the univariable logistic regression models, none of the tested factors showed influence on missing contralateral lesions. Four patients out of 35 (11%) with one positive LN at PSMA-PET had bilateral PCa recurrence.CONCLUSIONS: Patients with one-sided positive LNs on PSMA PET can be considered for a unilateral PSMA-radioguided SLND template with the caveat that about a quarter of patients ultimately have bilateral positive LNs. Larger prospective randomized trials are needed to confirm our findings.

AB - BACKGROUND: Defining the best surgical template for salvage lymph node dissection (SLND) in patients exhibiting unilateral prostate cancer (PCa) recurrence in pelvic lymph nodes (LNs) is an unmet need. We assessed the risk of missing contralateral nodal recurrence in patients with unilateral positive PSMA-PET who were treated with bilateral PSMA-radioguided (RGS) SLND.METHODS: Patients who consecutively underwent bilateral PSMA-radioguided SLND for PCa recurrence between April 2014 and January 2023 were identified. We compared PSMA PET findings with the number and the location of PCa LN metastases of the final pathological report. Univariable logistic regression models to try to predict contralateral missed disease were performed.RESULTS: Sixty patients were identified. At PSMA-RGS, the median PSA level was 0.71 ng/mL (IQR: 0.38-2.28). At PSMA-PET pre-SLND, 49 (82%) patients had unilateral exclusively pelvic lesions, 2 (3%) had unilateral positive nodes at the level of the common iliac arteries, and 9 (15%) had unilateral positive nodes in both levels. Final pathology revealed unilateral LN involvement in 43 (72%), a negative report in 3 (5%), and bilateral positive lesions in 14 (23%) patients. In the univariable logistic regression models, none of the tested factors showed influence on missing contralateral lesions. Four patients out of 35 (11%) with one positive LN at PSMA-PET had bilateral PCa recurrence.CONCLUSIONS: Patients with one-sided positive LNs on PSMA PET can be considered for a unilateral PSMA-radioguided SLND template with the caveat that about a quarter of patients ultimately have bilateral positive LNs. Larger prospective randomized trials are needed to confirm our findings.

KW - Male

KW - Humans

KW - Prevalence

KW - Prospective Studies

KW - Neoplasm Recurrence, Local/diagnostic imaging

KW - Prostatic Neoplasms/diagnostic imaging

KW - Positron-Emission Tomography

U2 - 10.23736/S2724-6051.23.05445-9

DO - 10.23736/S2724-6051.23.05445-9

M3 - SCORING: Journal article

C2 - 38126286

VL - 75

SP - 734

EP - 742

JO - MINERVA UROL NEPHROL

JF - MINERVA UROL NEPHROL

SN - 2724-6051

IS - 6

ER -